FARRAGUT PARTNERS LLP

Lobbying for HERON THERAPEUTICS, INC. · â€‹Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation

Medicare/Medicaid

Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.